archive-com.com » COM » O » ONCGNOSTICS.COM

Total: 361

Choose link from "Titles, links and description words view":

Or switch to "Titles and links view".
  • Investors and partners | oncgnostics GmbH
    high tech companies The innovative degree of the concept and the entrepreneurial potential are decisive for an investment without any focus on specific business areas The Erfurt based bm t beteiligungsmanagement thüringen gmbh a subsidiary of the Thüringer Aufbaubank is the management company for six investment funds with a total volume of 250 m bm t invests in innovative companies of all high yield sectors and in all stages of a company s life cycle from start up to IPO or MBO Since more than 185 years Sparkasse Jena Saale Holzland is a strong and reliable regional partner With its large branch network the consultants are always very close to the customers and can make decisions quickly and directly Sparkasse offers everything from giro account estate procurement and financing to business banking and corporate customer service As a public sector institution Sparkasse is dedicated to the common good the regional economic development and the people living in the area Anastasia Borghardt is Managing Shareholder of ITAI GmbH Aschaffenburg Germany a company which invests in small and medium sized enterprises having the perspective for success in growth markets Well positioned and innovative products are of prime importance for a positive investment decision Partners oncgnostics is part of the InfectoGnostics research campus in Jena which is a public private partnership developing new methods in infection diagnostics In a triad of technology application and production more than 30 partners from science medicine and industry are developing marketable solutions for rapid and cost effective diagnostics of infections Press Events Talks Professional opinions statements Investors and partners Investors contact Recent Posts Greiner Bio One starts international marketing of the cervical cancer triage test GynTect oncgnostics and Greiner Bio One Diagnostics sign Partnership Agreement Fast and reliable results in cancer diagnostics Biotech startup oncgnostics receives CE

    Original URL path: http://www.oncgnostics.com/for-investors-partners/investors-and-partners/?lang=en (2016-02-15)
    Open archived version from archive


  • Investors contact | oncgnostics GmbH
    Jobs News Blog Search Contact us Are you interested in oncgnostics Please do not hesitate and contact us via phone or email mailto alfred hansel oncgnostics com Dr Alfred Hansel Biologist CEO oncgnostics GmbH mailto martina schmitz oncgnostics com Dr Martina Schmitz Biochemist CSO oncgnostics GmbH oncgnostics GmbH BioInstrumentezentrum Jena Winzerlaer Str 2 07745 Jena Germany Management Dr Alfred Hansel Dr Martina Schmitz Phone 49 0 3641 508456 E Mail alfred hansel at oncgnostics com martina schmitz at oncgnostics com Press Events Talks Professional opinions statements Investors and partners Investors contact Recent Posts Greiner Bio One starts international marketing of the cervical cancer triage test GynTect oncgnostics and Greiner Bio One Diagnostics sign Partnership Agreement Fast and reliable results in cancer diagnostics Biotech startup oncgnostics receives CE mark for cervical cancer test GynTect Stay informed Enter your email address to subscribe to this blog and receive notifications of new posts by email Enter your Email Adress Our Topics GynTect Cervical cancer Information for patients Information for physicians Information for diagnostic laboratories Investors contact Recent Posts Greiner Bio One starts international marketing of the cervical cancer triage test GynTect oncgnostics and Greiner Bio One Diagnostics sign Partnership Agreement Fast and reliable

    Original URL path: http://www.oncgnostics.com/for-investors-partners/investors-contact/?lang=en (2016-02-15)
    Open archived version from archive

  • About oncgnostics | oncgnostics GmbH
    are specialized in the development of in vitro diagnostic tests for all areas of cancer diagnostics Our team A highly motivated team of staff with industry experience and highly motivated young scientists works at oncgnostics The management The founders of oncgnostics provide the management that steers the destiny of the company since its foundation How to find us oncgnostics has its office and labs at the Beutenberg campus in Jena Germany Please contact us if we have evoked your interest About us Management Advisory board Lab team History Pipeline Ovarian cancer Head and neck cancer Press Contact Access Jobs Recent Posts Greiner Bio One starts international marketing of the cervical cancer triage test GynTect oncgnostics and Greiner Bio One Diagnostics sign Partnership Agreement Fast and reliable results in cancer diagnostics Biotech startup oncgnostics receives CE mark for cervical cancer test GynTect Stay informed Enter your email address to subscribe to this blog and receive notifications of new posts by email Enter your Email Adress Our Topics GynTect Cervical cancer Information for patients Information for physicians Information for diagnostic laboratories Investors contact Recent Posts Greiner Bio One starts international marketing of the cervical cancer triage test GynTect oncgnostics and Greiner Bio

    Original URL path: http://www.oncgnostics.com/about-oncgnostics/?lang=en (2016-02-15)
    Open archived version from archive

  • About us | oncgnostics GmbH
    Juliane Hippe Biologist research development 8 Kristin Eichelkraut Pharma biotechnologist assaydevelopment research 9 Anne Hengst Pharma biotechnologist assaydevelopment 10 Susanne Jacob Bachelor Student Biotechnologist The oncgnostics team We at oncgnostics are specialized in the development of in vitro diagnostic tests for all areas of cancer diagnostics Our tests are based on epigenetic changes so called DNA methylations which are characteristic for cancer cells These highly informative biomarkers validated and patented by us represent the core of our products and provide the basis for our activities Our business strategy aims in the IVD test development field at after test validation and initial preclinical trials cooperation with international partners After registration products will be marketed directly or through licensing to cooperation or distribution partners contact contact at oncgnostics com oncgnostics awards and distinctions 2014 Thuringian Innovation Prize award for young companies 2014 Thuringian Innovation Prize nomination in the category light life 2013 Thuringian Research Prize to the oncgnostics founders 2013 Thuringian Elevator Pitch 2nd place companies 2012 Science4Life business plan contest top 10 2011 Founder contest Startbahn Ruhr Medical Industry 1st prize 2011 Thuringian Founder Prize winner young companies 2011 Thuringian Elevator Pitch winner young companies and projects Presentation of our company for the Thuringian Innovation Prize award for young companies german audiovisual elements An informative film about GynTect nominated for the Thuringian Innovation Prize in the category light life german audiovisual elements About us Management Advisory board Lab team History Pipeline Ovarian cancer Head and neck cancer Press Contact Access Jobs Recent Posts Greiner Bio One starts international marketing of the cervical cancer triage test GynTect oncgnostics and Greiner Bio One Diagnostics sign Partnership Agreement Fast and reliable results in cancer diagnostics Biotech startup oncgnostics receives CE mark for cervical cancer test GynTect Stay informed Enter your email address to subscribe

    Original URL path: http://www.oncgnostics.com/about-oncgnostics/about-us/?lang=en (2016-02-15)
    Open archived version from archive

  • Management | oncgnostics GmbH
    hospital which he has led oncgnostics GmbH https de linkedin com pub martina schmitz 86 419 896 https www xing com profile Martina Schmitz20 mailto martina schmitz oncgnostics com Dr Martina Schmitz Biochemist CSO As scientific head of oncgnostics Dr Schmitz is responsible for the development and registration of oncgnostics diagnostic tests During her scientific work at the Gynaecologic Molecular Biology unit head Prof Matthias Dürst she has already collected experience in test development multiplex PCR based HPV tests Besides she has profound knowledge concerning the biological mechanisms underlying HPV integration into the human genome Therefore she has high expertise within the business fields of oncgnostics oncgnostics GmbH mailto kerstin brox oncgnostics com https www xing com profile Kerstin Brox2 Kerstin Brox Economist finances Kerstin Brox is responsible for finances at oncgnostics She has 12 years of experience in private banking as well as 4 years experience as a purchase manager in an internationally active communication agency As a co founder Kerstin has already been part of the oncgnostics project team oncgnostics GmbH https de linkedin com pub peter haug 3 5a6 bb3 mailto peter haug oncgnostics com Dr Peter Haug Chemist economist head of business development licensing oncgnostics GmbH Dr Haug has five years of pharma industry exxperience where he was responsible for contracting cooperations as well as acquisition of other companies with a business volume of 250 m and 1500 employees successful negotiations with AstraZeneca Bristol Myers Genzyme Roche Since 2011 Peter is active as a founding angel with focus on young companies with whom he co operates as co founder and manager About us Management Advisory board Lab team History Pipeline Ovarian cancer Head and neck cancer Press Contact Access Jobs Recent Posts Greiner Bio One starts international marketing of the cervical cancer triage test GynTect oncgnostics

    Original URL path: http://www.oncgnostics.com/about-oncgnostics/management/?lang=en (2016-02-15)
    Open archived version from archive

  • Lab team | oncgnostics GmbH
    she brought essential know how into oncgnostics oncgnostics GmbH Kristina Wunsch Research development lab technician Kristina works for oncgnostics since October 2012 After an education as lab technician she has worked for several academic institutions and conpanies With her long term industry experience in reseach and development in the field of in vitro diagnostics she is essential for our team Besides experimental work in the R D field she organizes the oncgnostics lab oncgnostics GmbH Anne Hengst Biotechnologist Assay development Anne has joined oncgnostics in September 2013 and she strengthens the GynTect development team She has acquired basic laboratory skills during studies for a BSc and MSc in biotechnology and together with Dana Schmidt she works in the test development oncgnostics GmbH Juliane Hippe Biologist research Juliane has studied biology at the Friedrich Schiller University Jena Already with her diploma thesis in the Gynaecologic molecular biology of the university women s hospital she has contributed substantially to the GynTect marker identification and validation Now she performs studies for her PhD thesis in collaboration between the Dürst lab and oncgnostics These will focus on the role of the GynTect DNA methylation marker regions in carcinogenesis oncgnostics GmbH Kristin Eichelkraut Pharma Biotechnologist research development Kristin has joined oncgnostics in June 2015 and she works in the field of research and development She performs assays for clinical trials and is responsible for the improvement of pre analytics for a broader range of GynTect applications Kristin has already performed the practical part of her MSc thesis Pharma Biotechnology at oncgnostics oncgnostics GmbH About us Management Advisory board Lab team History Pipeline Ovarian cancer Head and neck cancer Press Contact Access Jobs Recent Posts Greiner Bio One starts international marketing of the cervical cancer triage test GynTect oncgnostics and Greiner Bio One Diagnostics sign Partnership

    Original URL path: http://www.oncgnostics.com/about-oncgnostics/lab-team/?lang=en (2016-02-15)
    Open archived version from archive

  • Advisory board | oncgnostics GmbH
    oncology guidelines program as well as as representative of the german society for gynaecology and obstetrics DGGG he is an important key opinion leader and can therefore support oncgnostics substantially with his advice oncgnostics GmbH Prof Dr Magnus von Knebel Doeberitz Director applied tumor biology university hospital Heidelberg Besides his profession as the head of applied tumor biology university hospital Heidelberg Prof von Knebel Doeberitz was co founder of mtm laboratories which was acquired by Roche Diagnostics in 2011 Therefore he has outstanding experience concerning positioning of tests especially in the field of cervical cancer diagnostics where he is an interntionally renowned expert oncgnostics GmbH Oliver Schacht PhD CEO Curetis AG Oliver Schacht head of Curetis AG has long lasting experience in leading positions in the diagnostics industry As co founder of Epigenomics AG he has invaluable industry insights in the field of epigenetic markers as well as cancer diagnostics Besides he has a very good network of business and investors contacts oncgnostics GmbH Consultants Prof Dr Matthias Dürst Virologist co founder and scientific cooperation partner oncgnostics GmbH Prof Dürst heads the functional unit Gynaecologic Molecular Biology at the University women s hospital Jena He is a dedicated expert in the field of human papillomaviruses carcinogenesis and HPV diagnostics He has contributed substantially to the research that led to the award of the Nobel prize for medicine to Prof Harald zur Hausen in 2008 Due to his long lasting experience in virus induced carcinogenesis and his contacts to the economy and science community he works as an advisor for oncgnostics About us Management Advisory board Lab team History Pipeline Ovarian cancer Head and neck cancer Press Contact Access Jobs Recent Posts Greiner Bio One starts international marketing of the cervical cancer triage test GynTect oncgnostics and Greiner Bio One Diagnostics

    Original URL path: http://www.oncgnostics.com/about-oncgnostics/advisory-board/?lang=en (2016-02-15)
    Open archived version from archive

  • History | oncgnostics GmbH
    Biology provided the basis for the spin off A subsequent EXIST research transfer project funded by the BMWi enabled the preparation of the foundation Since 08 2012 oncgnostics has its office and labs in the Bio instrumentation center BioInstrumentezentrum which is located at the Beutenberg Campus Jena Epigenetic markers for fast and reliable cervical cancer diagnostics the application of which we have patented provided the basis for the development of GynTect our first diagnostic test which may be used in early detection therapy decision and post surgical care We plan to patent markers for applications in further diagnostic fields Research and development as well as the management are certified according to ISO 9001 and ISO 13485 since early 2013 About us Management Advisory board Lab team History Pipeline Ovarian cancer Head and neck cancer Press Contact Access Jobs Recent Posts Greiner Bio One starts international marketing of the cervical cancer triage test GynTect oncgnostics and Greiner Bio One Diagnostics sign Partnership Agreement Fast and reliable results in cancer diagnostics Biotech startup oncgnostics receives CE mark for cervical cancer test GynTect Stay informed Enter your email address to subscribe to this blog and receive notifications of new posts by email Enter

    Original URL path: http://www.oncgnostics.com/about-oncgnostics/history/?lang=en (2016-02-15)
    Open archived version from archive



  •